Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Tecan’s AC Extraction Plate™ Boosts Productivity for Clozapine Testing
Saturday, October 25, 2014
King’s College Hospital has established a fully automated therapeutic drug monitoring protocol for clozapine.

Waters Introduces SEC Columns for Protein-Based Biotherapeutics Analysis
Thursday, October 16, 2014
New analytical columns feature hybrid particle technology and offer outstanding longevity, batch-to-batch consistency and reproducibility of results.

Improved Determination of Benzo(a)pyrene in Meat Products
Friday, October 10, 2014
An efficient HPLC method with fluorescence detection for sensitive and rapid determination of benzo[a]pyrene.

Phenomenex Introduces First Synthetic Sorbent for SLE
Wednesday, October 08, 2014
Novum Simplified Liquid Extraction - Ideal for the cleanup of biological samples.

Simultaneous Determination of Lithium, Sodium, and Calcium in Lithium Carbonate
Thursday, October 02, 2014
Thermo Fisher Scientific has developed an ion chromatography (IC)-based method to simultaneously determine lithium, sodium, and calcium in lithium carbonate without handling hazardous reagents.

Phenomenex Kinetex® EVO Core-Shell HPLC Columns
Wednesday, October 01, 2014
Deliver improved results and stability from pH 1 to 12.

Agilent Technologies’ Next-Generation UHPLC System
Tuesday, September 30, 2014
The 1290 Infinity II LC system sets new benchmark in laboratory efficiency.

Phenomenex Expands its Aeris® PEPTIDE Core-Shell Column Line
Thursday, September 18, 2014
The line now includes a 5 µm particle size for small-scale purifications.

Enhance Sample Preconcentration and Reduce Workflow
Thursday, September 18, 2014
New method developed by Thermo Fisher Scientific using solid-phase extraction well plates.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 779
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv